today announces the appointments of Elizabeth Holt as Chief Business Officer (CBO) and Dr Mark Velleca as Chair of the Board of Directors. Prior to her career in biopharmaceuticals, she was an ...
Elizabeth Holt, with a proven track record of forging successful life sciences partnerships, appointed as Chief Business Officer (CBO) Dr Mark Velleca appointed as Board Chair, bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback